Pilar Cruz
Known title: DirectorCIK: 0001723127
Associated companies
Transaction History
| DCI | ▲ Buy | Grant | 900 | $0 | 1/2/2026 | View on chart |
| DCI | ▲ Buy | Grant | 1,300 | $0 | 1/2/2025 | View on chart |
| DCI | ▲ Buy | Grant | 153 | $11K | 10/4/2024 | View on chart |
| DCI | ▲ Buy | Grant | 161 | $11K | 7/5/2024 | View on chart |
| DCI | ▲ Buy | Grant | 151 | $11K | 4/5/2024 | View on chart |
| DCI | ▲ Buy | Grant | 145 | $9K | 1/2/2024 | View on chart |
| DCI | ▲ Buy | Grant | 1,200 | $0 | 1/2/2024 | View on chart |
| DCI | ▲ Buy | Grant | 156 | $9K | 10/6/2023 | View on chart |
| DCI | ▲ Buy | Grant | 153 | $9K | 7/7/2023 | View on chart |
| DCI | ▲ Buy | Grant | 154 | $9K | 4/7/2023 | View on chart |
| DCI | ▲ Buy | Grant | 159 | $9K | 1/3/2023 | View on chart |
| DCI | ▲ Buy | Grant | 1,300 | $0 | 1/3/2023 | View on chart |
| DCI | ▲ Buy | Grant | 185 | $9K | 10/7/2022 | View on chart |
| DCI | ▲ Buy | Grant | 193 | $9K | 7/1/2022 | View on chart |
| DCI | ▲ Buy | Grant | 177 | $9K | 4/1/2022 | View on chart |
| DCI | ▲ Buy | Grant | 8 | $423 | 3/3/2022 | View on chart |
| DCI | ▲ Buy | Grant | 149 | $9K | 1/3/2022 | View on chart |
| DCI | ▲ Buy | Grant | 1,200 | $0 | 1/3/2022 | View on chart |
| DCI | ▲ Buy | Grant | 149 | $9K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Morgan Stanley Raises DCI Target to $95 After Earnings Beat
Donaldson reported an earnings beat and announced a new share buyback plan, which has drawn positive attention from analysts. Morgan Stanley maintained its Equal-Weight rating but raised its price target to $95, reflecting confidence in the company's durable cash flow. The stock is currently trading near its 52-week low, a level where some analysts suggest it may be undervalued.
Morgan Stanley Raises DCI Target to $95 After Earnings Beat. Donaldson reported an earnings beat and announced a new share buyback plan, which has drawn positive attention from analysts. Morgan Stanley maintained its Equal-Weight rating but raised its price target to $95, reflecting confidence in the company's durable cash flow. The stock is currently trading near its 52-week low, a level where some analysts suggest it may be undervalued.